LEADER 01428nam a2200301 u 4500
001 EB002000112
003 EBX01000000000000001163013
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
020 |a 9283212592 
020 |a 9789283212591 
245 0 0 |a Hepatitis viruses  |h Elektronische Ressource 
260 |a Lyon, France  |b International Agency for Research on Cancer  |c 1994, 1994 
300 |a 286 p.  |b ill 
505 0 |a Includes bibliographical references and index 
653 |a Hepatitis B virus / https://id.nlm.nih.gov/mesh/D006515 
653 |a Hepatitis Delta Virus / https://id.nlm.nih.gov/mesh/D003698 
653 |a Carcinoma, Hepatocellular / https://id.nlm.nih.gov/mesh/D006528 
653 |a Hepacivirus / https://id.nlm.nih.gov/mesh/D016174 
710 2 |a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans 
710 2 |a International Agency for Research on Cancer 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a IARC monographs on the evaluation of carcinogenic risks to humans 
500 |a "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 8-15 June 1993." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK513496  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610